Ernst Wagner, (Inventor), Ralf Kircheis, (Inventor), Daan Crommelin (Inventor), Maaike Van Slooten (Inventor), Gert Storm, (Inventor)

Research output: Patent


The invention relates to a tumour vaccine with a tumour antigen base. In addition to a source of tumour antigens, the vaccine contains a release system for the delayed release of the active agent IFN- gamma , the active dose of IFN- gamma being 50 ng to 5 mu g. The IFN- gamma is released over a period ranging from several hours to several days. The IFN- gamma release system consists preferably of liposomes, and the tumour antigen source preferably of allogenic tumour cells.

Original languageEnglish
Patent numberWO9920301
IPCA61P 35/ 00 A I
Priority date18/10/97
Publication statusPublished - 29 Apr 1999


Dive into the research topics of 'TUMOUR VACCINE'. Together they form a unique fingerprint.

Cite this